Conning Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Sell
250,532
-28,882
-10% -$4.04M 1.16% 38
2025
Q4
$34.3M Sell
279,414
-12,061
-4% -$1.47M 1.15% 19
2025
Q3
$32.4M Sell
291,475
-27,106
-9% -$3.08M 1.08% 48
2025
Q2
$35.3M Buy
318,581
+5,854
+2% +$623K 1.21% 30
2025
Q1
$35M Sell
312,727
-102,496
-25% -$10.6M 1.23% 34
2024
Q4
$38.4M Sell
415,223
-64,986
-14% -$5.85M 1.34% 7
2024
Q3
$40.3M Sell
480,209
-79,724
-14% -$6.08M 1.33% 16
2024
Q2
$38.4M Buy
559,933
+44,192
+9% +$2.95M 1.38% 9
2024
Q1
$37.7M Buy
515,741
+85,645
+20% +$6.59M 1.24% 37
2023
Q4
$34.8M Sell
430,096
-39,181
-8% -$3.05M 1.21% 24
2023
Q3
$35.1M Buy
469,277
+11,338
+2% +$872K 1.28% 16
2023
Q2
$35.2M Buy
457,939
+6,748
+1% +$538K 1.18% 43
2023
Q1
$37.4M Buy
451,191
+27,677
+7% +$2.29M 1.25% 24
2022
Q4
$36.3M Sell
423,514
-122,426
-22% -$9.69M 1.18% 24
2022
Q3
$33.6M Sell
545,940
-142,940
-21% -$9.01M 1.19% 21
2022
Q2
$42.5M Sell
688,880
-49,128
-7% -$3.04M 1.27% 22
2022
Q1
$43.8M Buy
738,008
+32,261
+5% +$2.06M 1.19% 35
2021
Q4
$51.2M Sell
705,747
-411
-0.1% -$28.3K 1.37% 26
2021
Q3
$49.3M Sell
706,158
-69,901
-9% -$4.91M 1.42% 18
2021
Q2
$53.4M Sell
776,059
-5,990
-0.8% -$400K 1.55% 9
2021
Q1
$50.5M Buy
782,049
+9,572
+1% +$617K 1.52% 26
2020
Q4
$45M Buy
772,477
+123,537
+19% +$7.45M 1.43% 33
2020
Q3
$41M Buy
648,940
+120,132
+23% +$8.33M 1.44% 30
2020
Q2
$40.7M Buy
528,808
+509,282
+2,608% +$39M 1.51% 25
2020
Q1
$1.46M Sell
19,526
-645
-3% -$44.6K 0.06% 149
2019
Q4
$1.31M Sell
20,171
-87,089
-81% -$5.67M 0.04% 181
2019
Q3
$6.8M Sell
107,260
-60
-0.1% -$3.92K 0.24% 78
2019
Q2
$7.25M Sell
107,320
-3,806
-3% -$250K 0.24% 78
2019
Q1
$7.22M Sell
111,126
-360
-0.3% -$23.9K 0.23% 81
2018
Q4
$6.97M Sell
111,486
-19,980
-15% -$1.4M 0.24% 78
2018
Q3
$9.84M Sell
131,466
-2,200
-2% -$166K 0.29% 73
2018
Q2
$9.17M Sell
133,666
-3,810
-3% -$269K 0.28% 74
2018
Q1
$9.99M Sell
137,476
-90
-0.1% -$7.15K 0.32% 69
2017
Q4
$9.53M Buy
137,566
+5,219
+4% +$396K 0.31% 77
2017
Q3
$10.5M Sell
132,347
-11,630
-8% -$889K 0.36% 70
2017
Q2
$9.82M Buy
143,977
+23,413
+19% +$1.56M 0.36% 71
2017
Q1
$8.19M Buy
120,564
+85,212
+241% +$5.99M 0.3% 75
2016
Q4
$2.53M Buy
35,352
+716
+2% +$53.2K 0.1% 153
2016
Q3
$2.74M Sell
34,636
-490
-1% -$39.8K 0.11% 148
2016
Q2
$2.93M Sell
35,126
-550
-2% -$48.8K 0.12% 139
2016
Q1
$3.28M Sell
35,676
-1,824
-5% -$164K 0.14% 125
2015
Q4
$3.79M Sell
37,500
-46
-0.1% -$4.79K 0.16% 117
2015
Q3
$3.69M Sell
37,546
-4,170
-10% -$463K 0.16% 111
2015
Q2
$4.88M Sell
41,716
-700
-2% -$76.5K 0.2% 91
2015
Q1
$4.16M Sell
42,416
-380
-0.9% -$38.6K 0.18% 94
2014
Q4
$4.03M Sell
42,796
-1,390
-3% -$144K 0.2% 90
2014
Q3
$4.7M Sell
44,186
-1,540
-3% -$151K 0.25% 81
2014
Q2
$3.79M Sell
45,726
-2,320
-5% -$181K 0.2% 89
2014
Q1
$3.4M Buy
48,046
+2,350
+5% +$184K 0.2% 97
2013
Q4
$3.43M Buy
45,696
+7,980
+21% +$556K 0.21% 98
2013
Q3
$2.37M Buy
37,716
+1,400
+4% +$83.7K 0.18% 107
2013
Q2
$1.86M Buy
+36,316
New +$1.89M 0.15% 119

Other funds holding GILD

Conning Inc's GILD Position: Q1 2026 in Review

Conning Inc reduced its Gilead Sciences (GILD) stake by 10% in Q1 2026, selling an estimated $4.04M and leaving 250,532 shares worth $34.9M. The position accounts for 1.16% of the portfolio, ranked #38.

Conning Inc first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $53.4M in Q2 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Conning Inc held 250,532 shares of Gilead Sciences worth $34.9M as of Q1 2026.
  • Conning Inc sold 28,882 Gilead Sciences shares in Q1 2026, an estimated $4.04M.
  • Gilead Sciences made up 1.16% of Conning Inc's portfolio in Q1 2026, its #38 holding.
  • Conning Inc first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Conning Inc's Gilead Sciences position peaked at $53.4M in Q2 2021.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.